| ACTH | Adrenocorticotropic hormone |
| ADHD | Hyperactive and/or attention-deficit disorder |
| AED | Antiepileptic drug |
| AKR1C2-4 | Aldo-keto reductase 1C2-4 |
| APOD | Apolipoprotein D |
| AR | Androgen receptor |
| ASD | Autism spectrum disorder |
| CDD | CDKL5 deficiency disorder |
| CE | Clustering epilepsy |
| Cg | Chorionic gonadotropin |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| DHT | Dihydrotestosterone |
| DSD | Disordered sexual development |
| ECoG | Electrocorticogram |
| ERα | Estrogen receptor α |
| GABAAR | γ-aminobutyric acid type A receptors |
| GRIA1 | Glutamate receptor 1 |
| iPSCs | Induced pluripotent stem cells |
| KO | Knock-out |
| MT | Mutant |
| NHR | Nuclear hormone receptor |
| NONO | Non-POU-domain-containing octamer-binding protein |
| OXT | Oxytocin |
| OXTR | Oxytocin receptor |
| PCDH19 | Protocadherin 19 |
| PGR | Progesterone receptor |
| PS | Pregnenolone sulfate |
| PTZ | Pentylenetetrazol |
| SWD | Spike-wave discharge |
| TBR2 | T-box brain protein 2 |
| WT | Wildtype |